1) inhibition of bacterial virulence
抑制细菌毒力
1.
RESULTS The action mechanism of macrolide drugs on PA infection is not through classic ribosomes (to combine with 50S subunits in bacterial ribosomes so to restrain the synthesis of bacterial protein) but to restrain or kill PA through immune regulation, anti-inflammation and inhibition of bacterial virulence.
结果大环内酯类药物对绿脓杆菌感染的作用不是通过经典的核糖体途径(与细菌核糖体的50S亚基结合,从而抑制细菌蛋白质合成),而是通过免疫调节、抗炎作用和抑制细菌毒力的作用来抑制或杀灭绿脓杆菌。
3) Bacterial virulence
细菌毒力
1.
Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium.
抗细菌毒力靶向药物治疗能选择性地遏制目标菌的不同毒力因子如黏附素、细菌毒素、Ⅲ型分泌系统、细菌生物膜、群体感应及双组分系统等,有效预防和治疗多种感染疾病。
4) Bacterial inhibition assay
细菌抑制法
6) bacteriostatic
[英][bæk,tiriəs'tætik] [美][bæk,tɪrɪəs'tætɪk]
细菌抑制的
补充资料：病原体毒力
病原体毒力
toxicity of pathogenic organisms
指病原体致病力的强弱程度，是量的概念。各种病原体的毒力不同，并随宿主不同及环境条件变化而异；同种病原体也常因型或株的不同而毒力有差异。常用半数致死量(LD50）或半数感染量(ID50）表示。构成毒力的病原体一般有侵袭力和毒素两个方面。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条